Genpact Capital Expenditure Trend from 2010 to 2022

G
 Stock
  

USD 43.12  0.46  1.08%   

Genpact Capital Expenditure is decreasing over the years with slightly volatile fluctuation. Capital Expenditure is expected to dwindle to -54,879,579. . As of June 30, 2022, Consolidated Income is expected to decline to about 343.7 M. In addition to that, Cost of Revenue is expected to decline to about 2.4 B.
  
Refresh
Check Genpact financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genpact main balance sheet or income statement drivers, such as Consolidated Income of 343.7 M or Cost of Revenue of 2.4 B, as well as many exotic indicators such as Asset Turnover of 0.9 or Book Value per Share of 9.47. Genpact financial statements analysis is a perfect complement when working with Genpact Valuation or Volatility modules. It can also supplement various Genpact Technical models. Please check the analysis of Genpact Correlation against competitors.

Genpact Capital Expenditure Breakdown

Showing smoothed Capital Expenditure of Genpact with missing and latest data points interpolated. A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of long-lived; physical & intangible assets that are used in the normal conduct of business to produce goods and services and are not intended for resale. Includes cash inflows/outflows to pay for construction of self-constructed assets & software.Genpact's Capital Expenditure historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genpact's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditure10 Years Trend
Decreasing
Slightly volatile
 Capital Expenditure 
Share
      Timeline 

Genpact Capital Expenditure Regression Statistics

Arithmetic Mean(71,778,506)
Coefficient Of Variation(47.24)
Mean Deviation 24,438,302
Median(62,013,000)
Standard Deviation 33,909,082
Range 124,889,000
R-Value(0.37)
R-Squared 0.13
Significance 0.22
Slope(3,182,893)

Genpact Capital Expenditure History

2012-82.8 M
2013-45.4 M
2014-62 M
2015-60.7 M
2016-88.2 M
2017-71.9 M
2018-159.7 M
2019-107 M
2020-79.8 M
2021-50.9 M
2022-54.9 M

About Genpact Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Genpact income statement, its balance sheet, and the statement of cash flows. Genpact investors use historical funamental indicators, such as Genpact's Capital Expenditure, to determine how well the company is positioned to perform in the future. Although Genpact investors may use each financial statement separately, they are all related. The changes in Genpact's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Genpact's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Genpact Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Genpact. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Capital Expenditure-50.9 M-54.9 M
Invested Capital2.8 B2.5 B
Invested Capital Average3.1 B2.7 B
Market Capitalization10 B8.5 B
Working Capital612.8 M648.1 M
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. The company was founded in 1997 and is based in Hamilton, Bermuda. Genpact operates under Information Technology Services classification in the United States and is traded on New York Stock Exchange. It employs 109600 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Genpact without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Genpact using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check the analysis of Genpact Correlation against competitors. Note that the Genpact information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Genpact Stock analysis

When running Genpact price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.085
Market Capitalization
7.8 B
Quarterly Revenue Growth YOY
0.13
Return On Assets
0.0659
Return On Equity
0.21
The market value of Genpact is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine Genpact value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.